116 related articles for article (PubMed ID: 35540700)
1. Chemotherapeutic potential of Cayratia trifolia L nhexane extract on A2780 cells.
Palanisamy CP; Pethanan S; Vincent GG; Murugesan K; Ramachandran A; Sivanandam R; Panagal M
Bioinformation; 2021; 17(8):710-714. PubMed ID: 35540700
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant, antimicrobial and cytotoxicity potential of n-hexane extract of Cayratia trifolia L.
Meganathan B; Palanisamy CP; Panagal M
Bioinformation; 2021; 17(3):452-459. PubMed ID: 34092965
[TBL] [Abstract][Full Text] [Related]
3. MTT assay based inhibition analysis of A2780 cells proliferation using
Palanisamy CP; Jh SF; Sekar R; Rajagopal P; Jeyaraman S
Bioinformation; 2021; 17(7):705-709. PubMed ID: 35283583
[TBL] [Abstract][Full Text] [Related]
4. Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression.
Matsui M; Adib-Conquy M; Coste A; Kumar-Roiné S; Pipy B; Laurent D; Pauillac S
J Ethnopharmacol; 2012 Aug; 143(1):24-32. PubMed ID: 22732725
[TBL] [Abstract][Full Text] [Related]
5. Control of human filarial vector, Culex quinquefasciatus Say 1823 (Diptera: Culicidae) through bioactive fraction of Cayratia trifolia leaf.
Chakraborty S; Singha S; Bhattacharya K; Chandra G
Asian Pac J Trop Biomed; 2013 Dec; 3(12):980-4. PubMed ID: 24093790
[TBL] [Abstract][Full Text] [Related]
6. A review on chemical and biological properties of Cayratia trifolia Linn. (Vitaceae).
Kumar D; Kumar S; Gupta J; Arya R; Gupta A
Pharmacogn Rev; 2011 Jul; 5(10):184-8. PubMed ID: 22279376
[TBL] [Abstract][Full Text] [Related]
7. Isolation, structural characterization and in silico drug-like properties prediction of a natural compound from the ethanolic extract of Cayratia trifolia (L.).
Perumal PC; Sowmya S; Pratibha P; Vidya B; Anusooriya P; Starlin T; Ravi S; Gopalakrishnan VK
Pharmacognosy Res; 2015; 7(1):121-5. PubMed ID: 25598646
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].
Huang L; Zhang QH; Ao QL; Xing H; Lu YP; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):96-100. PubMed ID: 17645840
[TBL] [Abstract][Full Text] [Related]
9. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
[No Abstract] [Full Text] [Related]
10. Experimental Validation of Antidiabetic Potential of
Mohammed SI; Salunkhe NS; Vishwakarma KS; Maheshwari VL
Indian J Clin Biochem; 2017 Jun; 32(2):153-162. PubMed ID: 28428689
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
12. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
13. Pharmacognostic evaluation of Cayratia trifolia (Linn.) leaf.
Kumar D; Gupta J; Kumar S; Arya R; Kumar T; Gupta A
Asian Pac J Trop Biomed; 2012 Jan; 2(1):6-10. PubMed ID: 23569825
[TBL] [Abstract][Full Text] [Related]
14. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
15. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
Miao F; Zhang X; Cao Y; Wang Y; Zhang X
BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
[TBL] [Abstract][Full Text] [Related]
17. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
18. The effects of crocetin, extracted from saffron, in chemotherapy against the incidence of multiple drug resistance phenotype.
Neyshaburinezhad N; Hashemi M; Ramezani M; Arabzadeh S; Behravan J; Kalalinia F
Iran J Basic Med Sci; 2018 Nov; 21(11):1192-1197. PubMed ID: 30483395
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780.
Wang M; Wu L; Wang L; Xin X
Biochem Biophys Res Commun; 2010 Feb; 393(1):144-9. PubMed ID: 20117093
[TBL] [Abstract][Full Text] [Related]
20. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192
[No Abstract] [Full Text] [Related]
[Next] [New Search]